SEARCH

SEARCH BY CITATION

References

  • 1
    Abumrad, N.A., El-Maghrabi, M.R., Amri, E., Lopez, E., Grimaldi, P.A. (1993) Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation: homology with human CD36. Journal of Biological Chemistry, 268, 17665 17668.
  • 2
    Ahn, Y.S., Harrington, W.J., Seelman, R.C., Eytel, C.S. (1974) Vincristine therapy of idiopathic and secondary thrombocytopenias. New England Journal of Medicine, 291, 376 380.
  • 3
    Amiral, J., Bridey, F., Dreyfus, M., Vissac, A.M., Fressinaud, E., Wolf, M., Meyer, D. (1992) Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thrombosis and Haemostasis, 68, 95 96.
  • 4
    Asch, A.S., Barnwell, J., Silverstein, R.J., Nachman, R.L. (1987) Isolation of the thrombospondin membrane receptor. Journal of Clinical Investigation, 79, 1054 1061.
  • 5
    Bird, G.W.G. (1977) Erythrocyte polyagglutination. Handbook Series in Clinical Laboratory Science, Section D: Blood Banking, Vol. I (ed. by T. J. Greenwalt and E. A. Steane), p. 443. CRC, Cleveland.
  • 6
    Burns, E.R. & Zucker-Franklin, D. (1982) Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells. Blood, 60, 1030 1037.
  • 7
    Chong, B.H., Fawaz, I., Chesterman, C.N., Berndt, M.C. (1989) Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets. British Journal of Haematology, 73, 235 240.
  • 8
    Daviet, L., Malvoisin, E., Wild, T.F., McGregor, J.L. (1997) Thrombospondin induces dimerization of membrane-bound, but not soluble CD36. Thrombosis and Haemostasis, 78, 897 901.
  • 9
    Daviet, L. & McGregor, J.L. (1997) Vascular biology of CD36: roles of this new adhesion molecule family in different disease states. Thrombosis and Haemostasis, 78, 65 69.
  • 10
    Endemann, G., Stanton, L.W., Madden, K.S., Bryant, C.M., White, R.T., Protter, A.A. (1993) CD36 is a receptor for oxidized low density lipoprotein. Journal of Biological Chemistry, 268, 11811 11816.
  • 11
    Good, D.J., Polverini, P.J., Rastinejad, F., LeBeau, M.M., Lemons, R.S., Frazier, W.A., Bouck, N.P. (1990) A tumor suppressor dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proceedings of the National Academy of Sciences of the United States of America, 87, 6624 6628.
  • 12
    Greenwalt, D.E., Lipsky, R.H., Ockenhouse, C.F., Ikeda, H., Tandon, N.N., Jamieson, G.A. (1992) Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood, 80, 1105 1115.
  • 13
    Greenwalt, D.E., Watt, K.W.K., So, O.Y., Jiwani, N. (1990) PAS IV, an integral membrane protein of mammary epithelial cells, is related to platelet and endothelial cell CD36 (GPIV). Biochemistry, 29, 7054 7059.
  • 14
    He, R., Reid, D.M., Jones, C.E., Shulman, N.R. (1994) Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. Blood, 83, 1024 1032.
  • 15
    Jaffe, E.A., Leung, L.L.K., Nachman, R.L., Levin, R.I., Mosher, D.F. (1982) Thrombospondin is the endogenous lectin of human platelets. Nature, 295, 246 248.
  • 16
    Karpatkin, S. (1997) Autoimmune (idiopathic) thrombocytopenic purpura. Lancet, 349, 1531 1536.
  • 17
    Kehrel, B., Wierwille, S., Clemetson, K.J., Anders, O., Steiner, M., Knight, C.G., Farndale, R.W., Okuma, M., Barnes, M.J. (1998) Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood, 91, 491 499.
  • 18
    Kelton, J.G., Sheridan, D., Santos, A., Smith, J., Steeves, K., Smith, C., Brown, C., Murphy, W.G. (1988) Heparin-induced thrombocytopenia: laboratory studies. Blood, 72, 925 930.
  • 19
    Kieffer, N., Bettaieb, A., Legrand, C., Coulombel, L., Vainchenker, W., Edelman, L., Breton-Gorius, J. (1989) Developmentally regulated expression of a 78 kDa erythroblast membrane glycoprotein immunologically related to the platelet thrombospondin receptor. Biochemical Journal, 262, 835 842.
  • 20
    Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680 684.
  • 21
    Leung, L.L.K. (1984) Role of thrombospondin in platelet aggregation. Journal of Clinical Investigation, 74, 1764 1772.
  • 22
    Macchi, L., Clofent-Sanchez, G., Marit, G., Bihour, C., Durrieu-Jais, C., Besse, P., Nurden, P., Nurden, A.T. (1996) PAICA: a method for characterizing platelet-associated antibodies — its application to the study of idiopathic thrombocytopenic purpura and to the detection of platelet-bound c7E3. Thrombosis and Haemostasis, 76, 1020 1029.
  • 23
    Majack, R.A., Goodman, L.V., Dixit, V.M. (1988) Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. Journal of Cell Biology, 106, 415 422.
  • 24
    McGregor, J.L., Catimel, B., Parmentier, S., Clezardin, P., Dechavanne, M., Leung, L.L.K. (1989) Rapid purification and partial characterization of human platelet glycoprotein IIIb. Journal of Biological Chemistry, 264, 501 506.
  • 25
    Murphy-Ullrich, J.E., Schultz-Cherry, S., Höök, M. (1992) Transforming growth factor β complexes with thrombospondin. Molecular Biology of the Cell, 3, 181 188.
  • 26
    Okumura, T. & Jamieson, G.A. (1976) Platelet glycocalicin: orientation of glycoproteins of the human platelet surface. Journal of Biological Chemistry, 251, 5944 5949.
  • 27
    Oquendo, P., Hundt, E., Lawler, J., Seed, B. (1989) CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell, 58, 95 101.
  • 28
    Pilatte, Y., Bignon, J., Lambré, C.R. (1993) Sialic acids as important molecules in the regulation of the immune system: pathophysiological implications of sialidases in immunity. Glycobiology, 3, 201 217.
  • 29
    Pfueller, S.L., David, R., Firkin, B.G., Bilston, R.A., Cortizo, W.F., Raines, G. (1990) Platelet aggregating IgG antibody to platelet surface glycoproteins associated with thrombosis and thrombocytopenia. British Journal of Haematology, 74, 336 341.
  • 30
    Raife, T.J., Atkinson, B.S., Aster, R.H., Gottschall, J.L. (1997) Minimal evidence for platelet or endothelial cell-reactive antibodies in thrombocytopenic purpura. (Abstract). Blood, 90, 462a.
  • 31
    Savill, J., Hogg, N., Ren, Y., Haslett, C. (1992) Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. Journal of Clinical Investigation, 90, 1513 1522.
  • 32
    Schauer, R. (1985) Sialic acids and their role as biological masks. Trends in Biochemical Science, 10, 357 360.
  • 33
    Silverstein, R.L., Asch, A.S., Nachman, R.L. (1989) Glycoprotein IV mediates thrombospondin-dependent platelet–monocyte and platelet–U937 cell adhesion. Journal of Clinical Investigation, 84, 546 552.
  • 34
    Silverstein, R.L., Leung, L.L.K., Harpel, P.C., Nachman, R.L. (1984) Complex formation of platelet thrombospondin with plasminogen: modulation of activation by tissue activator. Journal of Clinical Investigation, 74, 1625 1633.
  • 35
    Tandon, N.N., Kralisz, U., Jamieson, G.A. (1989 a) Identification of glycoprotein IV CD36) as a primary receptor for platelet–collagen adhesion. Journal of Biological Chemistry, 264, 7576 7583.
  • 36
    Tandon, N.N., Lipsky, R.H., Burgess, W.H., Jamieson, G.A. (1989 b) Isolation and characterization of platelet glycoprotein IV (CD36). Journal of Biological Chemistry, 264, 7570 7575.
  • 37
    Tandon, N.N., Rock, G., Jamieson, G.A. (1994) Anti-CD36 antibodies in thrombotic thrombocytopenic purpura. British Journal of Haematology, 88, 816 825.
  • 38
    Towbin, H., Staelin, T., Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences of the United States of America, 76, 4350 4354.
  • 39
    Valant, P.A., Jy, W., Horstman, L.L., Mao, W.W., Ahn, Y.S. (1998) Thrombotic thrombocytopenic purpura plasma enhances platelet–leucocyte interaction in vitro. British Journal of Haematology, 100, 24 32.
  • 40
    Vermylen, J., Hoylaerts, M.F., Arnout, J. (1997) Antibody-mediated thrombosis. Thrombosis and Haemostasis, 78, 420 426.
  • 41
    Yamamoto, N., Ikeda, H., Tandon, N.N., Herman, J., Tomiyama, Y., Mitani, T., Sekiguchi, S., Lipsky, R., Kralisz, U., Jamieson, G.A. (1990) A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka platelets lack detectable GP (IV) (CD36). Blood, 76, 1698 1703.